Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Arch begins phase II trial of LSALT to prevent COVID-19-related complications

Oct. 16, 2020

Unite and conquer approach finds shared weaknesses of coronaviruses

Oct. 16, 2020

MRT-5500 elicits neutralizing antibodies against SARS-CoV-2 in vivo

Oct. 16, 2020

Positive data from ILIAD study of peginterferon lambda in outpatients with COVID-19

Oct. 16, 2020

FDA clears IND to initiate phase Ib/IIa study of AP-PA02

Oct. 16, 2020

FDA approves Inmazeb for Zaire ebolavirus

Oct. 15, 2020

Sorrento cleared for phase II trial in Brazil of abivertinib for mild, moderate and severe COVID-19

Oct. 15, 2020

Novan presents positive in vitro data for its NITRICIL platform technology against SARS-CoV-2

Oct. 15, 2020

NIH launches ACTIV-5/BET trial to identify new promising COVID-19 treatments

Oct. 15, 2020

Enrollment begins in phase II ASUNCTIS study of asunercept in patients with COVID-19

Oct. 15, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...